Work

Reply to “Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real‐World Evidence”

Year: 2026

Type: letter

Source: Annals of Neurology

DOI: 10.1002/ana.78133

Authors: Gabriel Cerono, Bruce A. C. Cree, Stephen L. Hauser, Sergio E. Baranzini

Institution: University of California, San Francisco

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,700

OpenAlex ID: W7128696988

Cites: 2

Cited by: 1

Related to: